Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
Study acronym: Helping Hand
StatusRecruiting
PhasePhase 4
Started2024-06-04
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 3, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Amendment history
2025-08-01
minor
Study Status v2
Re-verified, no change to tracked fields
2024-08-16
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-01-01→confirmed 2024-06-04
Study sites0→1
2023-08-21
minor
Original filing
315 trials monitored
See 7 trials at risk
De Quervain disease is characterized by an adductor pollicis longus and extensor pollicis brevis tendons inflammation as thys pass beneath the extensor retinaculum at the radial styloid. This pathology is recognized as a musculoskeletal disorder of the upper limb triggering functional deficits resulting to possible modifications in the professional activity, sources of absenteeism, thus constituting an economic cost for society. At the etiological level, this pathology also affects young mothers (it's called "mother's wrist" or mommy thumb"), mobile phone users ("textonite", "Blackberryte") or video game players ("Nintendoite").
Currently, the treatment is mainly conservative by splint and anti-inflammatory gel and/or corticosteroid infiltration. Howewer, these therapies have undesirable effects. The interest of this study is therefore to propose another therapy based on aromatherapy gel.
| NCT Number |
NCT06012097 |
| Lead Sponsor |
University Hospital, Strasbourg, France
|
| Conditions |
De Quervain Disease |
| Enrollment |
70 participants |
| Start Date |
2024-06-04 |
| Primary Completion |
2026-04-01 (estimated) |
| Study Completion |
2026-04-01 (estimated) |
| Updated on ClinicalTrials.gov |
2025-08-03 |